HOW WE WORK
We bring structure to complex questions.
Our approach is collaborative, evidence-led and focused on decision impact. Built to bring clarity to programmes operating at the edge of science, execution and capital.
WHEN ORGANISATIONS TYPICALLY ENGAGE WITH CELLVANTA
Critical decisions often emerge long before problems become visible.
Preparing for a financing or partnership discussion
01
Ensuring technical narratives align with development reality and execution risk.
Evaluating platform or manufacturing readiness
02
Assessing whether technologies, processes and supporting infrastructure are ready for the next stage of development.
Planning major process or analytical changes
03
Understanding the comparability, regulatory and operational implications of change.
Assessing development risk
04
Identifying assumptions, dependencies and execution challenges before they become expensive to address.
Evaluating investment opportunities
05
Providing independent scientific and technical perspectives on readiness, manufacturability and development strategy.
Navigating uncertainty
06
Supporting teams facing decisions where the path forward is technically complex but time-sensitive.
ENGAGEMENT PRINCIPLES
Flexible engagement. Meaningful impact.
We work alongside you at pivotal moments. Bringing clarity, de-risking decisions and unlocking pathways forward.
✓ Strategic and technical advisory
✓ CMC and analytical development guidance
✓ Technical due diligence and TRL/MRL benchmarking
WHO WE PARTNER WITH
Founders. Innovators. Investors. Institutions.
United by a mission to improve lives.
Biotech & Startups
Founders building advanced therapy programmes.
Venture Capital & Investors
Funds, family offices and corporate venture teams.
Academic & Research Institutions
Translational science teams shaping clinical futures.
Industry & Strategic Partners
CDMOs, biotech companies and strategic collaborators.
Understand
01
We listen first. We align on objectives, constraints and the decision context (what success looks like), who needs to act on what we deliver and by when.
Assess
02
We evaluate data, assumptions, risks and technical realities by applying TRL/MRL frameworks alongside AI-enabled tooling where useful. Where evidence is incomplete, we say so.
Synthesise
03
We translate complexity into clear insights and strategic options. No padded reports. The output is what helps you decide and formatted for the audience that needs to act on it.
Deliver
04
We support confident decisions and stronger execution through clear recommendations, working sessions, network introductions and follow-through where it matters.

